Lai Kai Pharmaceutical Technology
PublicLai Kai Pharmaceutical Technology is now publicly traded
The data on this page reflects Lai Kai Pharmaceutical Technology's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 29, 2023
Last Round
Private Placement
Sep 24, 2025
Total Funding Raised
$344.31M
Company Overview
Laekna Therapeutics (HKG: 02105) is a biotechnology company focused on developing innovative therapies for cancer treatment through a robust R&D infrastructure and multiple clinical trials.
Sector
Biotech
AI Layer
Non-AI
Keywords
oral pan-AKT inhibitor for cancerclinical-stage cancer therapiescombination therapy for drug-resistant cancermetabolic disease drug developmentdrug candidate pipeline developmentbiotech drug in-licensingpharmaceutical co-development partnershipActRIIA antibody for obesitysmall molecule drug candidatesantibody-based therapeuticsCYP17A1/CYP11B2 inhibitor for prostate cancertherapies for solid tumorsanti-PD-L1 antibodyliver fibrosis therapies
Lai Kai Pharmaceutical Technology Comparables
Compare Lai Kai Pharmaceutical Technology with similar companies based on industry and business-model similarity.
Lai Kai Pharmaceutical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 24, 2025 | ||||
| IPO | Jun 29, 2023 | ||||
| Series D | May 18, 2022 | ||||
| Series C | Oct 1, 2020 | ||||
| Series B | Apr 2, 2019 | ||||
Series A | Jun 4, 2018 |
Lai Kai Pharmaceutical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed Asia | Series B, Series A |
| Yanchuang Capital | Series D |
| CS Capital | IPO, Series C, Series D |
| Ningbo Yaoshang Yanchuang Chenkai Venture Capital Partnership (Limited Partnership) | IPO |
| SDIC Innovation Investment Management | IPO |
| OrbiMed | Series B, Series A, IPO |
| Infinity Capital | Series D |
Lai Kai Pharmaceutical Technology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersShanghai, Shanghai
Year Founded2016
Last FundingSep 24, 2025